Innovation Pharmaceuticals Inc.
IPIX · OTC
6/30/2023 | 6/30/2022 | 6/30/2021 | 6/30/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | – | -100% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | -$0 | $0 | -$0 | $0 |
| % Margin | – | 100% | – | 100% |
| R&D Expenses | $1 | $5 | $7 | $3 |
| G&A Expenses | $1 | $2 | $2 | $2 |
| SG&A Expenses | $1 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3 | $7 | $9 | $5 |
| Operating Income | -$3 | -$7 | -$9 | -$5 |
| % Margin | – | -38,450% | – | -1,095.7% |
| Other Income/Exp. Net | -$0 | -$0 | -$5 | -$2 |
| Pre-Tax Income | -$3 | -$7 | -$14 | -$7 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3 | -$7 | -$14 | -$7 |
| % Margin | – | -39,116.7% | – | -1,571.6% |
| EPS | -0.006 | -0.014 | -0.036 | -0.03 |
| % Growth | 55% | 61% | -21.7% | – |
| EPS Diluted | -0.006 | -0.014 | -0.036 | -0.03 |
| Weighted Avg Shares Out | 506 | 504 | 386 | 237 |
| Weighted Avg Shares Out Dil | 506 | 504 | 386 | 237 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $5 | $0 |
| Interest Expense | $0 | $0 | $5 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$3 | -$7 | -$9 | -$6 |
| % Margin | – | -36,355.6% | – | -1,422% |